China Pharma (NYSE:CPHI) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com assumed coverage on shares of China Pharma (NYSE:CPHIGet Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Performance

Shares of CPHI opened at $0.24 on Wednesday. The stock’s 50 day moving average is $0.21 and its two-hundred day moving average is $0.22. China Pharma has a twelve month low of $0.13 and a twelve month high of $0.60. The company has a quick ratio of 0.26, a current ratio of 0.79 and a debt-to-equity ratio of 0.22.

China Pharma Company Profile

(Get Free Report)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People’s Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

See Also

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.